A major hurdle in managing type 2 diabetes (T2D) is a widespread gap in clinician awareness around the powerful, far-reaching benefits of GLP-1 receptor agonists (GLP-1 RAs). These innovative therapies help reduce the burden of cardiovascular, kidney, and metabolic (CKM) …
Clinicians face considerable hurdles when diagnosing and managing narcolepsy and idiopathic hypersomnia (IH), largely due to overlapping symptoms, insufficient formal training in sleep medicine, and limited recognition of associated psychiatric and cardiometabolic comorbidities. Compounding the challenge, some therapeutic agents—most notably …
Pre-exposure prophylaxis (PrEP) is an established and highly effective method of preventing sexually transmitted human immunodeficiency virus (HIV) infections and has been instrumental in declining incidence rates. Adherence and access to HIV prevention still pose challenges due to stigma and …
Pre-exposure prophylaxis (PrEP) is an established and highly effective method of preventing sexually transmitted human immunodeficiency virus (HIV) infections and has been instrumental in declining incidence rates. Adherence and access to HIV prevention still pose challenges due to stigma and …
OVERVIEW Early career rheumatologists and pulmonologists with an interest in interstitial lung diseases (ILDs) are invited to attend the 2025 Early Career Professional Program on Interstitial Lung Disease (ECPP-ILD). Ideal candidates are committed to improving their diagnostic skills, expanding their understanding …
Traditional diagnosis and treatment of Alzheimer’s disease (AD) has relied heavily on the clinical expertise of healthcare professionals (HCPs) and patient-reported symptoms. However, recently revised diagnostic criteria incorporate biomarkers—such as amyloid and tau pathology—and advanced imaging modalities, including amyloid, tau, …
Traditional diagnosis and treatment of Alzheimer’s disease (AD) has relied heavily on the clinical expertise of healthcare professionals (HCPs) and patient-reported symptoms. However, recently revised diagnostic criteria incorporate biomarkers—such as amyloid and tau pathology—and advanced imaging modalities, including amyloid, tau, …
Generalized myasthenia gravis (gMG) is a chronic neuromuscular disorder that results from destruction of the neuromuscular junction by pathogenic autoantibodies, partially through the actions of the neonatal Fc receptor (FcRn). Traditional therapies only partially alleviate the heavy disease burden and …
Acromegaly presents a diagnostic and management challenge due to its gradual onset, diverse symptoms, and complex treatment landscape. Delays in diagnosis and suboptimal care lead to prolonged morbidity and increased mortality. However, emerging therapies, including novel oral options, offer new …